Hydrogen-induced disruption of the airway mucus barrier enhances nebulized RNA delivery to reverse pulmonary fibrosis
Open Access
- 18 April 2025
- journal article
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 11 (16) , eadt2752
Abstract
Nebulized RNA therapies are well suited for treating respiratory diseases, in particular pulmonary fibrosis (PF); however, effective delivery remains challenging. In this study, we present a highly efficient aerosol inhalation system that enables high levels of in vivo transfection efficiency in lung macrophages, yielding durable responses against PF. First, we established a nose-only aerosol inhalation device integrated with a hydrogen supplement system. This setup enables the precise administration of lipid nanoparticles (LNPs) at a controlled low dose, while simultaneously delivering the optimal concentration of therapeutic hydrogen gas. We further developed a hybrid lipid NP (HNP) by hybridizing a pH-dependent charge-inverting lipid film with apoptotic T cell membranes to enhance endosomal escape and trigger macrophage production of hepatocyte growth factor for lung repair. We demonstrated that the hydrogen flow–induced shear stresses disrupt the NP-mucus interaction, enhancing the deposition of aerosolized HNPs/ TGF β 1 siRNA within fibrotic lung lesions, effectively blocking fibrogenic signaling pathways and offering a clinically viable strategy for combating PF.Keywords
This publication has 55 references indexed in Scilit:
- Intratracheal bleomycin causes airway remodeling and airflow obstruction in miceExperimental Lung Research, 2012
- Hydrogen inhalation ameliorates ventilator-induced lung injuryCritical Care, 2010
- Antifibrotic Effect of Hepatocyte Growth Factor-Expressing Mesenchymal Stem Cells in Small-for-Size Liver Transplant RatsStem Cells and Development, 2010
- Hepatocyte Growth Factor Inhibits Epithelial to Myofibroblast Transition in Lung Cells via Smad7American Journal of Respiratory Cell and Molecular Biology, 2009
- Hepatocyte Growth Factor Exerts Its Anti-Inflammatory Action by Disrupting Nuclear Factor-κB SignalingThe American Journal of Pathology, 2008
- Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicalsNature Medicine, 2007
- Gene transfer of hepatocyte growth factor by electroporation reduces bleomycin-induced lung fibrosisAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2007
- Hepatocyte Growth Factor Protects Small Airway Epithelial Cells from Apoptosis Induced by Tumor Necrosis Factor-α or Oxidative StressPediatric Research, 2004
- Hepatocyte Growth Factor Attenuates Collagen Accumulation in a Murine Model of Pulmonary FibrosisAmerican Journal of Respiratory and Critical Care Medicine, 2000
- Simple method of estimating severity of pulmonary fibrosis on a numerical scale.Journal of Clinical Pathology, 1988